Clinical Trial

Low Voltage Electrical Stimulation for Depression in Parkinson's Patients

Study acronym: LVESDIPP
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to determine the relative efficacy of fMRI model guided Transcranial Direct Current Stimulation (mgTDCS) in improving the depressive symptoms of patients with Parkinson's Disease (PD). The main questions it aims to answer are: 1) Can the use of mgTDCS significantly improve the self-reported level of depression and apathy in patients with PD from pre-intervention to post-intervention compared to a sham control? 2) Can the use of mgTDCS significantly normalize the cortical eeg alpha asymmetry so commonly seen in depressed patients compared to sham mgTDCS? 3) Can the use of mgTDCS significantly improve scores on neuropsychological tests of working memory?
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-14.
Status change: Not Yet Recruiting → Recruiting 2026-04-01
Trial Details
NCT Number NCT06467695
Lead Sponsor University of South Alabama
Conditions Parkinson Disease, Depressive Symptoms
Enrollment 40 participants
Start Date 2024-08-01
Primary Completion 2027-05-01 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-06